Alibaba Health Information Technology Limited EBIT

As of the most recent data (March 2026), ALBBY shows a EBIT of $1.6B. That compares with $860M in the prior-year period — up 84.2% year over year. That is below the Healthcare sector average of $23B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ALBBY's EBIT is now $1.6B (was $860M) — a 84.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Alibaba Health Information Technology Limited is outperforming or lagging.

The Healthcare sector average EBIT is about $23B. Alibaba Health Information Technology Limited is at $1.6B, which is lower that average. That is roughly 93.1% below the sector mean. Use the comparison chart on this page to see how ALBBY stacks up against individual peers as well.

Tracking ALBBY's ebit over time shows whether Alibaba Health Information Technology Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $1.6B That compares with $860M in the prior-year period — up 84.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Alibaba Health Information Technology Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $1.6B) with ownership activity and broader fundamentals.